CD35: Complement receptor type 1

Journal of Biological Regulators and Homeostatic Agents

Volumn 13, Issue 4, 1999, Pages 229-233

  Krych, M ^a   Molina, H ^a   Atkinson, J P ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR;

ALLOTYPE; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; COMPLEMENT ACTIVATION; DENDRITIC CELL; ERYTHROCYTE; GRANULOCYTE; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE ADHERENCE; LEISHMANIA; MOLECULAR SIZE; MONOCYTE; MOUSE; MYCOBACTERIUM; NOMENCLATURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOCYTOSIS; PODOCYTE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TISSUE DISTRIBUTION;

EID: 0033303363     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Identification of an alternative polyadenylation site in the human C3b/C4b receptor (CR1) transcriptional unit and prediction of a secreted form of CR1
2. Human C3b/C4b receptor (CR1): Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3b/C4b binding proteins
3. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism
4. The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosus
5. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele
6. The murine complement receptor gene family. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1
7. Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1
8. Identification of complement receptor type 1-related proteins on primate erythrocytes
9. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B-lymphocyte and monocyte
10. CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review
11. Human follicular dentritic cells express CR1, CR2, and CR3 complement receptor antigens
12. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor
13. Complement expression in human brain
14. Identification of a C3b/C4b binding protein of rabbit platelets and leukocytes: A CR1-like candidate for the immune adherence receptor
15. In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets
16. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1)
17. Monoclonal antibodies to mouse complement receptor type 1 (CR1): Their use in a distribution study showing that mouse erythrocytes and platelets are CR1 negative
18. Structural and functional correlation of the human complement receptor type 1
19. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function
20. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2
21. Analysis of the functional domains of complement receptor type 1 (C3b/C4b receptor; CD35) by substitution mutagenesis
22. Structure-function analysis of the active sites of complement receptor type 1
23. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding
24. The clearance of immune complexes from the circulation of man and other primates
25. The immune adherence phenomenon
26. Physiological and pathological aspects of circulating immune complexes
27. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane
28. Complement receptor is an inhibitor of the complement cascade
29. Complement receptor type 1 (CR1, CD35) is a receptor for C1q
30. Signaling properties of CR3 (CD11b/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles
31. Functional analysis of complement receptor 1 using a new monoclonal antibody
32. Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1,CD35) on human monocytes
33. C3 cleavage products stimulate release of prostaglandins by human mononuclear phagocytes in vitro
34. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B-cells
35. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B-cell differentiation
36. Disruption of the CR2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen
37. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
38. Complement evasion strategies of microorganisms
39. CR1 (CD35) and CR3 (CD11b/CD18) mediate infection of human monocytes and monocytic cell lines with complement-opsonized HIV independently of CD4
40. Immune complexes and the role of complement
41. Decreased expression of the C3b/C4b complement receptor (CR1) in AIDS and AIDS-related syndromes correlates with clinical subpopulations of patien ts with HIV infection
42. Decreased levels of complement receptor 1 (CD35) on B-lymphocytes in persons with HIV infection
43. Falciparam rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1
44. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in experimental allergic encephalomyelitis
45. Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis
46. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury
47. The effect of soluble complement receptor type 1 in hyperacute xenograft rejection
48. Soluble human complement receptor type I: In vivo inhibitor of complement suppressing post ischemic myocardial inflammation and necrosis
49. Novel complement inhibitors
50. Complement inhibitors as therapeutic agents
51. Reference typing report for complement receptor 1 (CR1)
52. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: Negative and weak reactions are caused by variable expression of CR1
53. The C3b/C4b receptor is recognized by Knops, McCoy, Swain-Langley and York blood group antisera
54. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor
55. Mapping epitopes for 20 monocional antibodies to CR1